Welcome to LookChem.com Sign In|Join Free
  • or
5-(3-fluorophenyl)thiazol-2-ylamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

438585-95-6

Post Buying Request

438585-95-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

438585-95-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 438585-95-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,8,5,8 and 5 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 438585-95:
(8*4)+(7*3)+(6*8)+(5*5)+(4*8)+(3*5)+(2*9)+(1*5)=196
196 % 10 = 6
So 438585-95-6 is a valid CAS Registry Number.

438585-95-6Relevant academic research and scientific papers

NOVEL KINASE INHIBITORS

-

Paragraph 0210, (2014/05/07)

The present invention provides derivatives of thiazolylamino-substituted heterocycles. These compounds are inhibitors of kinases, including compounds that show antiproliferative activity against cells, including against tumor cells, and are useful in the treatment of diseases including cancer.

3,8-DIAZA-BICYCLO[4.2.0]OCT-8-YL AMIDES

-

, (2012/07/13)

The present invention relates to 3,8-diaza-bicyclo[4.2.0]oct-8-yl amide derivatives of formula (I) Formula (I) wherein the relative configuration of the diazabicyclooctane moiety is cis; and wherein Ar1, and Ar 2 are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as orexin receptor antagonists.

3,8-DIAZA-BICYCLO[4.2.0]OCT-3-YL AMIDES

-

, (2012/07/13)

The present invention relates to 3,8-diaza-bicyclo[4.2.0]oct-3-yl amide derivatives of formula (I), wherein the relative configuration of the diazabicyclooctane moiety is cis; and wherein Ar1, and Ar2 are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as orexin receptor antagonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 438585-95-6